4Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol, 2001,108 : S147- S336. 被引量：1
5Gotzsche PC, Hammerquist C, Burr M. House dust mite control measures in the management of asthma: meta analysis. BMJ, 1998,317 : 1105-1110. 被引量：1
6Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical allergen-specific immunotherapy. Allergy, 2006, 61 (Suppl. 82) :1-20. 被引量：1
7Maasch HJ, Wahl R. Preparation of human serum pools for allergen specific IgE : criteria for selection and reproducibility. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M, 1988, 82 : 117-127. 被引量：1
8Carreira J, Lombardero M, Ventas P. New developments in in vitro methods. Quantification of clinically relevant allergens in mass units. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M, 1994,87 : 155-166. 被引量：1
9Nelson HS. The use of standardized extracts in allergen immunotherapy. J Allergy Clin Immunol, 2000,106:41-45. 被引量：1
10Keating MU, Kagey-Sobotka A, Hamilton RG, et al. Clinical and immunologic follow-up of patients who stop venom immunotherapy. J Allergy Clin Immunol, 1991,88:339-348. 被引量：1
